Organigram Global (NASDAQ:OGI – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.
Profitability
This table compares Organigram Global and KORU Medical Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Organigram Global | 28.14% | -13.39% | -8.67% |
| KORU Medical Systems | -4.03% | -10.63% | -6.51% |
Volatility and Risk
Organigram Global has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500.
Insider and Institutional Ownership
Earnings & Valuation
This table compares Organigram Global and KORU Medical Systems”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Organigram Global | $309.18 million | 0.48 | -$17.70 million | $0.46 | 2.28 |
| KORU Medical Systems | $45.11 million | 3.29 | -$2.64 million | ($0.04) | -80.75 |
KORU Medical Systems has lower revenue, but higher earnings than Organigram Global. KORU Medical Systems is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and target prices for Organigram Global and KORU Medical Systems, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Organigram Global | 1 | 0 | 2 | 0 | 2.33 |
| KORU Medical Systems | 1 | 0 | 4 | 0 | 2.60 |
KORU Medical Systems has a consensus price target of $7.00, indicating a potential upside of 116.72%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Organigram Global.
Summary
KORU Medical Systems beats Organigram Global on 9 of the 14 factors compared between the two stocks.
About Organigram Global
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Organigram Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram Global and related companies with MarketBeat.com's FREE daily email newsletter.
